Accelerate Diagnostics Inc. (NASDAQ: AXDX) kicked off on June 22, 2022, at the price of $0.88, up 28.15% from the previous trading day. During the day, the shares moved up to $1.12 and dropped to $0.88 before settling in for the closing price of $0.87. Over the past 52 weeks, AXDX has traded in a range of $0.50-$9.28.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 116.80%. While this was happening, its average annual earnings per share was recorded 9.80%. With a float of $51.12 million, this company’s outstanding shares have now reached $67.75 million.
The extent of productivity of a business whose workforce counts for 220 workers is very important to gauge. In terms of profitability, gross margin is -3.23, operating margin of -607.37, and the pretax margin is -659.12.
Accelerate Diagnostics Inc. (AXDX) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Diagnostics & Research Industry. The insider ownership of Accelerate Diagnostics Inc. is 0.40%, while institutional ownership is 29.30%. The most recent insider transaction that took place on Apr 28, was worth 29,317. In this transaction Chief Financial Officer of this company sold 29,915 shares at a rate of $0.98, taking the stock ownership to the 62,493 shares. Before that another transaction happened on Apr 28, when Company’s Chief Executive Officer sold 83,708 for $0.98, making the entire transaction worth $82,034. This insider now owns 208,073 shares in total.
Accelerate Diagnostics Inc. (AXDX) Latest Financial update
In the latest quarterly report, which was put into the public domain on 12/30/2021, the organization reported -$0.35 earnings per share (EPS), lower than consensus estimate (set at -$0.25) by -$0.1. This company achieved a net margin of -659.50. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.3 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 9.80% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 30.00% during the next five years compared to 0.60% growth over the previous five years of trading.
Accelerate Diagnostics Inc. (NASDAQ: AXDX) Trading Performance Indicators
Take a look at Accelerate Diagnostics Inc.’s (AXDX) current performance indicators. Last quarter, stock had a quick ratio of 6.80. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.54.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.06, a number that is poised to hit -0.28 in the next quarter and is forecasted to reach -0.42 in one year’s time.
Technical Analysis of Accelerate Diagnostics Inc. (AXDX)
The latest stats from [Accelerate Diagnostics Inc., AXDX] show that its last 5-days average volume of 1.37 million was superior to 0.7 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 64.54%. Additionally, its Average True Range was 0.15.
During the past 100 days, Accelerate Diagnostics Inc.’s (AXDX) raw stochastic average was set at 21.55%, which indicates a significant decrease from 79.02% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 326.68% in the past 14 days, which was higher than the 155.40% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.8099, while its 200-day Moving Average is $3.4327. Now, the first resistance to watch is $1.2000. This is followed by the second major resistance level at $1.2800. The third major resistance level sits at $1.4400. If the price goes on to break the first support level at $0.9600, it is likely to go to the next support level at $0.8000. The third support level lies at $0.7200 if the price breaches the second support level.
Accelerate Diagnostics Inc. (NASDAQ: AXDX) Key Stats
The company with the Market Capitalisation of 92.04 million has total of 69,661K Shares Outstanding. Its annual sales at the moment are 11,780 K in contrast with the sum of -77,700 K annual income. Company’s last quarter sales were recorded 2,960 K and last quarter income was -14,190 K.
